January 4, 2018 / 12:24 PM / in 9 minutes BRIEF-Psivida Granted Waiver By The FDA For New Drug Application Filing Fee Reuters Staff 
Jan 4 (Reuters) - Psivida Corp: 
* PSIVIDA GRANTED WAIVER BY THE FDA FOR NEW DRUG APPLICATION FILING FEE 
* PSIVIDA CORP - ON TRACK TO FILE DURASERT NDA IN EARLY JANUARY 
* PSIVIDA - FDA GRANTED BUSINESS WAIVER OF PDUFA FEE OF ABOUT $2.4 MILLION FOR NDA FOR COâ€˜S DURASERT 3 YEAR MICROINSERT FOR POSTERIOR SEGMENT UVEITIS Source text for Eikon: Further company coverage: